Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05886894 · ClinicalTrials.gov registry record
Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses
A clinical trial, sponsored by Alcon Research.
- Completed
- Registry status
- 351
- Enrollment target
NCT05886894: Completed study, sponsored by Alcon Research.
NCT05886894 is a clinical trial that has completed, run by Alcon Research. The registered enrollment target is 351 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05886894 has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- 351 participants
- Enrollment target
Study Summary
The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term performance and safety of Air Optix plus HydraGlyde Multifocal soft contact lenses in a real-world setting when worn as daily wear or extended (overnight) wear.
Primary Outcome
The subject's chart will be reviewed for distance visual acuity at Year 1, defined as the visit which occurred 1 year (-2/+4 months) since baseline, during which period the subject was wearing the protocol required contact lenses and a contact lens examination was performed. This outcome measure is prespecified for the daily wear arms (Air Optix plus HydraGlyde Multifocal Daily Wear and Biofinity Multifocal Daily Wear).
Interventions
- DEVICE Lotrafilcon B multifocal soft contact lenses
- DEVICE Comfilcon A multifocal soft contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 351 participants |
| Start Date | 2023-08-08 |
| Est. Completion | 2025-06-20 |
What the finished NCT05886894 record still lists
NCT05886894 is an observational study that tracks outcomes without assigning an intervention. The registered 351 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Lotrafilcon B multifocal soft contact lenses is the first listed.
NCT05886894 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05886894 about?
NCT05886894 is a clinical study titled "Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses". The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term performance and safety of Air Optix plus HydraGlyde Multifocal soft contact lenses in a real-world setting when worn as daily wear or extended (overnight) wear.
What is the current status of trial NCT05886894?
This trial is currently completed. The enrollment target is 351 participants. The study started on 2023-08-08. Estimated completion is 2025-06-20.
What interventions are being tested in trial NCT05886894?
The interventions under investigation include: Lotrafilcon B multifocal soft contact lenses (DEVICE), Comfilcon A multifocal soft contact lenses (DEVICE).
Who is sponsoring clinical trial NCT05886894?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06241456 · 351 participants · Phase 1
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
- NCT06576726 · 351 participants
Sensorimotor and Psychosocial Trajectories in Adolescents With Tic Disorder
- NCT07043400 · 351 participants · Phase 3
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT07261423 · 351 participants · NA
Pollution Intervention to Impact Kids Asthma Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI